Mylash Launches Latisse In The UK

Online, May 9, 2011 (Newswire.com) - Latisse is a drug from the makers of Botox that grows eyelashes when it is applied to the base of them. Latisse achieved American FDA approval for cosmetic use 2008 millions of units have been sold in America alone.

Latisse is being launched in the UK by Mylash, the UK experts in eyelash growth.

Although Mylash currently offers treatment to grow your eyelashes using bimatoprost, the same active ingredient as Latisse, Mylash thinks that the Latisse brand will help attract customers.

'People follow the US market looking for the next big thing and many will have heard about Latisse. The treatment we currently offer has the same active ingredient but we feel that additionally offering Latisse will help attract customers.' said Dr Walker, director of Mylash.

Mylash has been a celebrity eyelash secret in London for the past 18 months with models, singers and even British royalty using the service.

Mylash will provide Latisse in the UK online. All consultations are reviewed by British doctors before a prescription is issued.

The average results for Mylash or Latisse is a 25% increase in length, 106% increase in thickness and 18% darker lashes.

For more information, visit www.Mylash.org